ABOS   $2.72  1.87% Market Open

Acumen Pharmaceuticals, Inc.

EMA (20): 2026-02-06 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (50): 2026-01-22 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (100): 2026-01-22 the price crossed up the moving average line and demonstrates a strong upside trend.

RSI: RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: entrance to the overbought zone.

Stochastic: The stochastic indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: entrance to the overbought zone.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 37.92%
EMA (20) date of signal Feb. 6, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 66.33%
EMA (50) date of signal Jan. 22, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 66.33%
EMA (100) date of signal Jan. 22, 2026, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 19.93%
RSI (14) date of signal Feb. 24, 2026, 3 a.m.
MACD Signals bullish recovery
MACD Yield 19.93%
MACD date of signal Feb. 24, 2026, 3 a.m.
Stochastic Signals bullish recovery
Stochastic Yield 19.93%
Stochastic date of signal Feb. 24, 2026, 3 a.m.
Updated March 4, 2026, 8:05 p.m.